Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kahori Sonoda
Institution:
Kyushu University
Observed institutions:
Kurume University,
Kyushu University,
Nagasaki International University,
St Mary's Hospital,
Kurume University Hospital,
Hospital Universitario Dexeus
show all 6
OpenAlex ID:
A5111896684
Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2013
·
Rina Kanda
, Akihiko Kawahara
, et al.
·
Cancer Research
·
176
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor
2014
·
Koichi Azuma
, Akihiko Kawahara
, et al.
·
Oncotarget
·
117
PDF
Overcoming drug resistance to receptor tyrosine kinase inhibitors: Learning from lung cancer
2016
·
Michihiko Kuwano
, Kahori Sonoda
, et al.
·
Pharmacology & Therapeutics
·
76
Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells
2012
·
Keisuke Tabara
, Rina Kanda
, et al.
·
PLoS ONE
·
76
PDF
Sorting nexin 2‐mediated membrane trafficking of c‐ M et contributes to sensitivity of molecular‐targeted drugs
2013
·
Sayaka Ogi
, Hideaki Fujita
, et al.
·
Cancer Science
·
34
PDF
The activation of SRC family kinases and focal adhesion kinase with the loss of the amplified, mutatedEGFRgene contributes to the resistance to afatinib, erlotinib and osimertinib in human lung cancer cells
2017
·
Yuichi Murakami
, Kahori Sonoda
, et al.
·
Oncotarget
·
32
PDF
Supplementary Table 1 from Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2023
·
Rina Kanda
, Akihiko Kawahara
, et al.
PDF
Supplementary Figure 2 from Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2023
·
Rina Kanda
, Akihiko Kawahara
, et al.
PDF
Supplementary Figure 1 from Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2023
·
Rina Kanda
, Akihiko Kawahara
, et al.
Supplementary Materials and Methods from Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2023
·
Rina Kanda
, Akihiko Kawahara
, et al.
PDF
Supplementary Figure Legends from Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2023
·
Rina Kanda
, Akihiko Kawahara
, et al.
PDF
Supplementary Figure 3 from Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2023
·
Rina Kanda
, Akihiko Kawahara
, et al.
PDF
Data from Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2023
·
Rina Kanda
, Akihiko Kawahara
, et al.
Data from Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
2023
·
Rina Kanda
, Akihiko Kawahara
, et al.
Abstract LB-B02: Acquisition of stem cell-like properties accompanying with Src family kinase/Focal adhesion kinase activation contributes to acquired resistance to afatinib in lung cancer cells
2015
·
Yuichi Murakami
, Kahori Sonoda
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
15
Citation count:
511
H-index:
6
I10-index:
6
Year
Topic
Type